Bone plate

Details for Australian Patent Application No. 2005245007 (hide)

Owner HFSC Company

Inventors Grady, Mark P. Jr; Bolhofner, Brett R.; Koay, Kenny; Mayo, Keith A.; Mast, Jeff W.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005245007

PCT Pub. Number WO2005/112802

Priority 10/851,849 21.05.04 US

Filing date 19 May 2005

Wipo publication date 1 December 2005

International Classifications

A61B 17/56 (2006.01) Surgery - Surgical instruments or methods for treatment of bones or joints

A61B 17/58 (2006.01) Surgery - for osteosynthesis, e.g. bone plates, screws or the like

A61B 17/80 (2006.01) Surgery

A61F 2/30 (2006.01) Filters - Joints

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/112802 Priority application(s): WO2005/112802

14 May 2009 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the Name HFSC Company, Application No. 2005245007, under INID (71) correct the name to read Synthes GmbH

15 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005245008-Anti-cancer activity of an anti-thymidine kinase monoclonal antibody

2005245004-Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound